Abstract
Over the last few decades, molecular neurobiology has uncovered many genes whose deficiency in mice results in behavioral traits associated with human neuropsychiatric disorders such as autism, obsessive-compulsive disorder (OCD), and schizophrenia. However, the etiology of these common diseases remains enigmatic with the potential involvement of a battery of genes. Here, we report abnormal behavioral phenotypes of mice deficient in a cell adhesion molecule Ninjurin 1 (Ninj1), which are relevant to repetitive and anxiety behaviors of neuropsychiatric disorders. Ninj1 knockout (KO) mice exhibit compulsive grooming-induced hair loss and self-made lesions as well as increased anxiety-like behaviors. Histological analysis reveals that Ninj1 is predominantly expressed in cortico-thalamic circuits, and neuron-specific Ninj1 conditional KO mice manifest aberrant phenotypes similar to the global Ninj1 KO mice. Notably, the brains of Ninj1 KO mice display altered synaptic transmission in thalamic neurons as well as a reduced number of functional synapses. Moreover, the disruption of Ninj1 leads to glutamatergic abnormalities, including increased ionotropic glutamate receptors but reduced glutamate levels. Furthermore, chronic treatment with fluoxetine, a drug reportedly ameliorates compulsive behaviors in mice, prevents progression of hair loss and alleviates the compulsive grooming and anxiety-like behavior of Ninj1 KO mice. Collectively, our results suggest that Ninj1 could be involved in neuropsychiatric disorders associated with impairments of repetitive and anxiety behaviors.
Similar content being viewed by others
Abbreviations
- ASD:
-
Autism spectrum disorder
- AMPA:
-
α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
- CNS:
-
Central nervous system
- CSTC:
-
Cortico-striatal-thalamo-cortical
- EPM:
-
Elevated plus maze
- KO:
-
Knockout mice
- Ninj1:
-
Nerve injury-induced protein 1
- NMDA:
-
N-methyl-D-aspartate
- OCD:
-
Obsessive-compulsive disorder
- OFT:
-
Open field test
- PBS:
-
Phosphate-buffered saline
- SSRI:
-
Selective serotonin reuptake inhibitor
- SEM:
-
Standard errors of the mean
- WT:
-
Wild-type
References
Hyman SE (2008) A glimmer of light for neuropsychiatric disorders. Nature 455(7215):890–893
Taber KH, Hurley RA, Yudofsky SC (2010) Diagnosis and treatment of neuropsychiatric disorders. Annu Rev Med 61:121–133
Whiteford HA, Ferrari AJ, Degenhardt L, Feigin V, Vos T (2015) The global burden of mental, neurological and substance use disorders: an analysis from the Global Burden of Disease Study 2010. PLoS One 10(2):e0116820
Pauls DL, Abramovitch A, Rauch SL, Geller DA (2014) Obsessive-compulsive disorder: an integrative genetic and neurobiological perspective. Nat Rev Neurosci 15(6):410–424
Subramaniam M, Soh P, Vaingankar JA, Picco L, Chong SA (2013) Quality of life in obsessive-compulsive disorder: impact of the disorder and of treatment. CNS Drugs 27(5):367–383
Chou IH, Chouard T (2008) Neuropsychiatric disease. Nature 455(7215):889
Fernando AB, Robbins TW (2011) Animal models of neuropsychiatric disorders. Annu Rev Clin Psychol 7:39–61
Peca J, Feliciano C, Ting JT, Wang W, Wells MF, Venkatraman TN, Lascola CD, Fu Z et al (2011) Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature 472(7344):437–442
Won H, Lee HR, Gee HY, Mah W, Kim JI, Lee J, Ha S, Chung C et al (2012) Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function. Nature 486(7402):261–265
Ahmari SE (2015) Using mice to model obsessive compulsive disorder: from genes to circuits. Neuroscience 321:121–137
Schmeisser MJ (2015) Translational neurobiology in Shank mutant mice-model systems for neuropsychiatric disorders. Ann Anat 200:115–117
Stachowiak MK, Kucinski A, Curl R, Syposs C, Yang Y, Narla S, Terranova C, Prokop D et al (2013) Schizophrenia: a neurodevelopmental disorder-integrative genomic hypothesis and therapeutic implications from a transgenic mouse model. Schizophr Res 143(2–3):367–376
Schmeisser MJ, Ey E, Wegener S, Bockmann J, Stempel AV, Kuebler A, Janssen AL, Udvardi PT et al (2012) Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2. Nature 486(7402):256–260
Shmelkov SV, Hormigo A, Jing D, Proenca CC, Bath KG, Milde T, Shmelkov E, Kushner JS et al (2010) Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive-like behaviors in mice. Nat Med 16(5):598–602
Welch JM, Lu J, Rodriguiz RM, Trotta NC, Peca J, Ding JD, Feliciano C, Chen M et al (2007) Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. Nature 448(7156):894–900
Dalva MB, McClelland AC, Kayser MS (2007) Cell adhesion molecules: signalling functions at the synapse. Nat Rev Neurosci 8(3):206–220
Moya PR, Dodman NH, Timpano KR, Rubenstein LM, Rana Z, Fried RL, Reichardt LF, Heiman GA et al (2013) Rare missense neuronal cadherin gene (CDH2) variants in specific obsessive-compulsive disorder and Tourette disorder phenotypes. Eur J Hum Genet 21(8):850–854
O’Dushlaine C, Kenny E, Heron E, Donohoe G, Gill M, Morris D, Corvin A (2011) Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility. Mol Psychiatry 16(3):286–292
Proenca CC, Gao KP, Shmelkov SV, Rafii S, Lee FS (2011) Slitrks as emerging candidate genes involved in neuropsychiatric disorders. Trends Neurosci 34(3):143–153
Morrow EM, Yoo SY, Flavell SW, Kim TK, Lin Y, Hill RS, Mukaddes NM, Balkhy S et al (2008) Identifying autism loci and genes by tracing recent shared ancestry. Science 321(5886):218–223
Araki T, Milbrandt J (1996) Ninjurin, a novel adhesion molecule, is induced by nerve injury and promotes axonal growth. Neuron 17(2):353–361
Araki T, Zimonjic DB, Popescu NC, Milbrandt J (1997) Mechanism of homophilic binding mediated by ninjurin, a novel widely expressed adhesion molecule. J Biol Chem 272(34):21373–21380
Ahn BJ, Le H, Shin MW, Bae SJ, Lee EJ, Wee HJ, Cha JH, Lee HJ et al (2014) Ninjurin1 deficiency attenuates susceptibility of experimental autoimmune encephalomyelitis in mice. J Biol Chem 289(6):3328–3338
Shin MW, Bae SJ, Wee HJ, Lee HJ, Ahn BJ, Le H, Lee EJ, Kim RH et al (2016) Ninjurin1 regulates lipopolysaccharide-induced inflammation through direct binding. Int J Oncol 48(2):821–828
Ifergan I, Kebir H, Terouz S, Alvarez JI, Lecuyer MA, Gendron S, Bourbonniere L, Dunay IR et al (2011) Role of Ninjurin-1 in the migration of myeloid cells to central nervous system inflammatory lesions. Ann Neurol 70(5):751–763
Matsuki M, Kabara M, Saito Y, Shimamura K, Minoshima A, Nishimura M, Aonuma T, Takehara N et al (2015) Ninjurin1 is a novel factor to regulate angiogenesis through the function of pericytes. Circ J 79(6):1363–1371
Jang YS, Kang JH, Woo JK, Kim HM, Hwang JI, Lee SJ, Lee HY, Oh SH (2016) Ninjurin1 suppresses metastatic property of lung cancer cells through inhibition of interleukin 6 signaling pathway. Int J Cancer 139(2):383–395
Greer JM, Capecchi MR (2002) Hoxb8 is required for normal grooming behavior in mice. Neuron 33(1):23–34
Skarnes WC, Rosen B, West AP, Koutsourakis M, Bushell W, Iyer V, Mujica AO, Thomas M et al (2011) A conditional knockout resource for the genome-wide study of mouse gene function. Nature 474(7351):337–342
Angoa-Perez M, Kane MJ, Briggs DI, Francescutti DM, Kuhn DM (2013) Marble burying and nestlet shredding as tests of repetitive, compulsive-like behaviors in mice. J Vis Exp 82:50978
Ahn BJ, Le H, Shin MW, Bae SJ, Lee EJ, Wee HJ, Cha JH, Park JH et al (2012) The N-terminal ectodomain of Ninjurin1 liberated by MMP9 has chemotactic activity. Biochem Biophys Res Commun 428(4):438–444
Wang X, Bey AL, Katz BM, Badea A, Kim N, David LK, Duffney LJ, Kumar S et al (2016) Altered mGluR5-Homer scaffolds and corticostriatal connectivity in a Shank3 complete knockout model of autism. Nat Commun 7:11459
Garner JP, Weisker SM, Dufour B, Mench JA (2004) Barbering (fur and whisker trimming) by laboratory mice as a model of human trichotillomania and obsessive-compulsive spectrum disorders. Comp Med 54(2):216–224
Carcani-Rathwell I, Rabe-Hasketh S, Santosh PJ (2006) Repetitive and stereotyped behaviours in pervasive developmental disorders. J Child Psychol Psychiatry 47(6):573–581
Kalueff AV, Stewart AM, Song C, Berridge KC, Graybiel AM, Fentress JC (2016) Neurobiology of rodent self-grooming and its value for translational neuroscience. Nat Rev Neurosci 17(1):45–59
Leckman JF, Denys D, Simpson HB, Mataix-Cols D, Hollander E, Saxena S, Miguel EC, Rauch SL et al (2010) Obsessive-compulsive disorder: a review of the diagnostic criteria and possible subtypes and dimensional specifiers for DSM-V. Depress Anxiety 27(6):507–527
Reaven J (2011) The treatment of anxiety symptoms in youth with high-functioning autism spectrum disorders: developmental considerations for parents. Brain Res 1380:255–263
Ting JT, Feng G (2008) Glutamatergic synaptic dysfunction and obsessive-compulsive disorder. Curr Chem Genomics 2:62–75
Ting JT, Feng G (2011) Neurobiology of obsessive-compulsive disorder: insights into neural circuitry dysfunction through mouse genetics. Curr Opin Neurobiol 21(6):842–848
Pittenger C, Bloch MH, Williams K (2011) Glutamate abnormalities in obsessive-compulsive disorder: neurobiology, pathophysiology, and treatment. Pharmacol Ther 132(3):314–332
Lee EJ, Choi SY, Kim E (2015) NMDA receptor dysfunction in autism spectrum disorders. Curr Opin Pharmacol 20:8–13
Lin CH, Lane HY, Tsai GE (2012) Glutamate signaling in the pathophysiology and therapy of schizophrenia. Pharmacol Biochem Behav 100(4):665–677
Wu K, Hanna GL, Rosenberg DR, Arnold PD (2012) The role of glutamate signaling in the pathogenesis and treatment of obsessive-compulsive disorder. Pharmacol Biochem Behav 100(4):726–735
Goddard AW, Shekhar A, Whiteman AF, McDougle CJ (2008) Serotoninergic mechanisms in the treatment of obsessive-compulsive disorder. Drug Discov Today 13(7–8):325–332
Sarter M, Bruno JP, Parikh V (2007) Abnormal neurotransmitter release underlying behavioral and cognitive disorders: toward concepts of dynamic and function-specific dysregulation. Neuropsychopharmacology 32(7):1452–1461
Ahmari SE, Spellman T, Douglass NL, Kheirbek MA, Simpson HB, Deisseroth K, Gordon JA, Hen R (2013) Repeated cortico-striatal stimulation generates persistent OCD-like behavior. Science 340(6137):1234–1239
Milad MR, Rauch SL (2012) Obsessive-compulsive disorder: beyond segregated cortico-striatal pathways. Trends Cogn Sci 16(1):43–51
Velikova S, Locatelli M, Insacco C, Smeraldi E, Comi G, Leocani L (2010) Dysfunctional brain circuitry in obsessive-compulsive disorder: source and coherence analysis of EEG rhythms. NeuroImage 49(1):977–983
Chakrabarty K, Bhattacharyya S, Christopher R, Khanna S (2005) Glutamatergic dysfunction in OCD. Neuropsychopharmacology 30(9):1735–1740
Kariuki-Nyuthe C, Gomez-Mancilla B, Stein DJ (2014) Obsessive-compulsive disorder and the glutamatergic system. Curr Opin Psychiatry 27(1):32–37
Spooren W, Lindemann L, Ghosh A, Santarelli L (2012) Synapse dysfunction in autism: a molecular medicine approach to drug discovery in neurodevelopmental disorders. Trends Pharmacol Sci 33(12):669–684
Duman RS, Aghajanian GK (2012) Synaptic dysfunction in depression: potential therapeutic targets. Science 338(6103):68–72
van Spronsen M, Hoogenraad CC (2010) Synapse pathology in psychiatric and neurologic disease. Curr Neurol Neurosci Rep 10(3):207–214
Crabtree GW, Gogos JA (2014) Synaptic plasticity, neural circuits, and the emerging role of altered short-term information processing in schizophrenia. Front Synaptic Neurosci 6:28
Bourgeron T (2015) From the genetic architecture to synaptic plasticity in autism spectrum disorder. Nat Rev Neurosci 16(9):551–563
Wong DT, Perry KW, Bymaster FP (2005) Case history: the discovery of fluoxetine hydrochloride (Prozac). Nat Rev Drug Discov 4(9):764–774
Li YF, Zhang YZ, Liu YQ, Wang HL, Cao JB, Guan TT, Luo ZP (2006) Inhibition of N-methyl-D-aspartate receptor function appears to be one of the common actions for antidepressants. J Psychopharmacol 20(5):629–635
Szasz BK, Mike A, Karoly R, Gerevich Z, Illes P, Vizi ES, Kiss JP (2007) Direct inhibitory effect of fluoxetine on N-methyl-D-aspartate receptors in the central nervous system. Biol Psychiatry 62(11):1303–1309
Kiss JP, Szasz BK, Fodor L, Mike A, Lenkey N, Kurko D, Nagy J, Vizi ES (2012) GluN2B-containing NMDA receptors as possible targets for the neuroprotective and antidepressant effects of fluoxetine. Neurochem Int 60(2):170–176
Acknowledgments
The authors thank Dr. Ji-Hyeon Park for animal behavior assistance; Dr. Hyun-Ho Kim for confocal microscopy setting; Hoang-Kieu-Chi Ngo for discussions, comments, and reading of the manuscript; Dr. Jeongjin Kim and Minju Jeong (Dept. of Biological Sciences, KAIST, Korea) for the electrophysiological experiments; and Dr. Melinda Chan and KOMP project (UC Davis, USA) for Ninj1 tm1a mice. This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Ministry of Education, Science and Technology (MEST) through the Global Research Laboratory Program (2011-0021874), Brain Korea 21 Program (2013-036038), the Global Core Research Center (GCRC) Program (2011-0030001), the NRF grant funded by the Korea government (MSIP) (2015R1C1A2A01054446 to H.S. Lee), Basic Science Research Program (2013R1A1A2058956 to J.H. Seo), and the International Cooperation Program (2014K2A1C2074279). E.H. Lo is the recipient of NIH grants (R37-NS37074, R01-76694, and P01-NS55104). G.T.O. was supported by the NRF grant funded by the Korea government (MEST) (No. 2013003407).
Author Contribution
H.L. performed biological, behavioral experiments, constructed Ninj1 conditional knockout mice, analyzed data, prepared the figure, and wrote the manuscript. B.J.A. constructed Ninj1 knockout mice system and Ninj1 antibody, analyzed data, prepared the figure, and edited the manuscript. H.S.L. coordinated collaborations, analyzed data, and prepared the figure and manuscript. S.Y.L. performed behavioral tests, electron microscopy. M.W.S. helped with biological experiments and edited the manuscript. E.-J.L. prepared Ninj1 antibody. J.-H.C. helped with immunostaining, animal experiments, and data discussion. J.H.S., H.-J.W., T.S., and E.H.L. helped with discussion of hypothesis. Y.W.J. gave antibodies of synaptic proteins and helped with data discussion. H.-J.L. initiated Ninj1 study and helped with data discussion. S.J.J. and G.T.O. provided Ninj1 knockout mice. A.N.S., S.J.C., and D.S.K. conducted electrophysiological experiments. H.L. and K.-W.K. developed the hypothesis. K.-W.K. supervised this project, analyzed data, and wrote the manuscript. All authors read and approved the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Le, H., Ahn, B.J., Lee, H.S. et al. Disruption of Ninjurin1 Leads to Repetitive and Anxiety-Like Behaviors in Mice. Mol Neurobiol 54, 7353–7368 (2017). https://doi.org/10.1007/s12035-016-0207-6
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1007/s12035-016-0207-6